当前位置:首页 >英文主页 >中英对照 > 中译版报告详情

Biomedtracker:2026年JPM医疗大会报告-Day3(中译版)(31页).pdf

上传人: 1****1 编号:1079730 2026-01-22 31页 1.58MB

下载:

1、A CLEARER VIEW FROM#JPM2026#JPM2026 DAY 3 UPDATEComplete coverage,context and commercial insights from healthcares biggest symposium.2 Biomedtracker JPM2026 Day 3 Update#JPM2026 Day 3 Update Copyright 2026 Summary The 44th annual J.P.Morgan Healthcare Conference(JPM)is being held in San Francisco,CA

2、 over January 12-15,2026.This report contains presentation highlights from a selection of companies from Day 3 of the conference.Stay tuned for Biomedtrackers full real-time coverage of the 2026 J.P.Morgan Healthcare Conference.Our daily reports published each evening will bring you the important pi

3、peline updates and key takeaways from the entire days presentations.With our platforms helping you navigate along the way,youll stay informed on the latest updates in drug development and not miss a beat from the biggest investor healthcare conference of the year.About the Author Biomedtracker is an

4、 independent research service that offers proprietary clinical assessments and patient-based revenue forecasts of developmental drugs within a comprehensive and intuitive drug information database.Clients from the pharmaceutical,biotech,and investment industries rely on Biomedtracker for its insight

5、 on the likelihood of approval,commercial potential,and future data and regulatory catalysts for drugs within the competitive landscape of every important disease and indication.Over the last several years,Biomedtracker has become the leader in providing objective information alongside evidencebased

6、 clinical assessments and investment research on pipeline drugs worldwide.For more information on getting direct access to Biomedtracker,please email .Disclaimer Copyright 2026 Evaluate,a Norstella company.This report is published by Evaluate(the Publisher).This report contains information from repu

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **会议概况**:2026年J.P.摩根医疗大会(#JPM2026)于1月12-15日在旧金山举行,Biomedtracker发布每日报告,聚焦管线更新与核心洞察。 2. **大型药企动态**: - **艾伯维**:Skyrizi和Rinvoq驱动增长,2025年销售额增长70亿美元,预计2027年达310亿美元;神经科学板块(如Botox)为最快增长业务。 - **UCB**:2025年营收增长24%,Bimzelx在50国获批,2026年美国覆盖人群预计增25%。 3. **中型药企进展**: - **Arcus**:HIF-2抑制剂casdatifan在肾癌III期PEAK-1试验中入组加速,预计2028年数据。 - **Disc Medicine**:EPP疗法bitopertin获FDA加速审批,潜在市场20亿美元;贫血疗法DISC-0974预计2026年读出数据。 4. **小型药企亮点**: - **4D Molecular**:4D-150(湿AMD/DME疗法)III期试验入组400例,现金储备5.14亿美元。 - **Agios**:Aqvesme(地中海贫血疗法)2025年获批,现金13亿美元。 - **Kyverna**:CAR-T疗法KYV-101用于僵人综合征,III期试验81%患者改善,2026年提交BLA。
**AbbVie新药前景?** **CAR-T疗法突破?** **罕见病治疗进展?**
客服
商务合作
小程序
服务号
折叠